Reed John C's Form 4 filing
Johnson & Johnson (JNJ) · filed Oct 20, 2025
- Accession no.
- 0000200406-25-000204
- Filed
- Oct 20, 2025
- Trade date
- Oct 17, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.19M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reed John CCIK 0001181561 | Officer (EVP, Innovative Medicine, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | Common Stock | MOption exerciseAcquired | +21,721 | $157.92 | +$3,430,180.32 | 32,379 | Direct | |
| Oct 17, 2025 | Common Stock | SSaleDisposed | −21,721 | $192.71F1 | −$4,185,853.91 | 10,658 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | Common Stock | MOption exerciseDisposed | −21,721 | $157.92 | −$3,430,180.32 | 43,442 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $192.69 to $192.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.